Executive Branch

Biden Administration Inks $3.2 Billion Deal With Pfizer for 105 Million COVID Vaccine Doses

Biden Administration Inks $3.2 Billion Deal With Pfizer for 105 Million COVID Vaccine Doses
President Joe Biden receives a third dose of the Pfizer/BioNTech COVID-19 vaccine in the South Court Auditorium in the White House on Sept. 27, 2021. Anna Moneymaker/Getty Images
Tom Ozimek
Tom Ozimek
Reporter
|Updated:
0:00

The Biden administration signed a new agreement with Pfizer and partner BioNTech on June 29 for 105 million doses of their COVID-19 vaccine for a fall vaccination campaign, in a deal valued at $3.2 billion.

The contract includes doses for both adults and children, as well as supplies of a retooled Omicron-adapted vaccine that’s currently pending approval by federal health authorities, the Department of Health and Human Services (HHS) said in a statement.

Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics